Showing results (301-310 of 342) with videos related to

Sort By:
Pageof 35
Respiratory Investigation|October 15, 2021
Transient leukocytopenia following combination therapy for COVID-19Kazuo Tsuchiya, Tomoyuki Fujisawa, Yasutaka Mochizuka, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 6, 2019
Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPDYuzo Suzuki, Naoki Inui, Masato Karayama, et al.
The European Respiratory Journal|February 23, 2023
A predictive model for acute exacerbation of idiopathic interstitial pneumoniasMasato Karayama, Yoichiro Aoshima, Takahito Suzuki, et al.
Respirology (Carlton, Vic.)|November 3, 2023
Association of the lung immune prognostic index with the survival of patients with idiopathic interstitial pneumoniasTakahito Suzuki, Masato Karayama, Yoichiro Aoshima, et al.
The European Respiratory Journal|July 7, 2022
Idiopathic pleuroparenchymal fibroelastosis: three-dimensional computed tomography assessment of upper-lobe lung volumeAtsuki Fukada, Yuzo Suzuki, Kazutaka Mori, et al.
Respiratory Medicine and Research|October 30, 2025
Long-acting muscarinic antagonist versus leukotriene receptor antagonist as additional treatment in uncontrolled asthma patients used inhaled corticosteroids and long-acting β2 adrenergic agonist: a randomized phase 2 screening trialFumiya Nihashi, Kazuki Furuhashi, Mitsuru Niwa, et al.
Journal of Cancer Research and Clinical Oncology|July 14, 2022
Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancerYusuke Inoue, Naoki Inui, Masato Karayama, et al.
Cancer Medicine|August 29, 2023
First-line nivolumab, paclitaxel, carboplatin, and bevacizumab for advanced non-squamous non-small cell lung cancer: Updated survival analysis of the ONO-4538-52/TASUKI-52 randomized controlled trialHye Ryun Kim, Shunichi Sugawara, Jong-Seok Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 15, 2020
Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective StudyYuzo Suzuki, Masato Karayama, Tomohiro Uto, et al.
BMC Pulmonary Medicine|October 3, 2021
Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysisKoichi Miyashita, Masato Karayama, Yusuke Inoue, et al.
Pageof 35